[Evaluating the efficacy of anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis disease]
Feyz-Journal of Kashan University of Medical Sciences. 2010; 13 (4): 278-284
in Persian
| IMEMR
| ID: emr-197218
ABSTRACT
Background:
Rheumatoid arthritis is one of the most common autoimmune diseases. Early diagnosis can prevent side effects and disability. Anti-cyclic citrullinated peptide antibody is a specific marker to diagnose rheumatoid arthritis. This study was carried out to evaluate the efficacy of anti-cyclic citrullinated peptide in comparison with rheumatoid factor in rheumatoid arthritis patients referred to Behshti Hospital of Kashan city during 2006-7
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Screening study
Language:
Persian
Journal:
J. Kashan Univ. Med. Sci.
Year:
2010
Similar
MEDLINE
...
LILACS
LIS